Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| DTCK | Davis Commodities | $2.62 | $1.19 | 83.27% | 8.9M | $39M | $1.32$137.80 |
| TURB | Turbo Energy | $5.86 | $2.08 | 54.89% | 8.5M | $42M | $0.57$20.45 |
| XENE | Xenon Pharmaceuticals | $60.13 | $18.19 | 43.37% | 349.7K | $3.5B | $26.74$62.40 |
| HIMS | Hims & Hers Health | $21.58 | $5.84 | 37.11% | 69.1M | $3.6B | $13.74$70.43 |
| RLMD | Relmada Therapeutics | $5.89 | $1.44 | 32.41% | 27.8M | $326M | $0.24$6.52 |
| ANTX | An2 Therapeutics | $3.76 | $0.91 | 31.93% | 5.3M | $78M | $1.00$3.83 |
| DNTH | Dianthus Therapeutics | $80.74 | $15.54 | 23.83% | 1.9M | $2.8B | $13.37$84.86 |
| PROP | Prairie Operating, Llc | $1.98 | $0.38 | 23.51% | 4.2M | $95M | $1.50$6.90 |
| RGNX | Regenxbio | $10.40 | $1.75 | 20.17% | 804.8K | $438M | $5.04$16.19 |
| NCSM | Ncs Multistage | $58.09 | $9.74 | 20.14% | 450 | $123M | $25.09$58.09 |
| LSTA | Lisata Therapeutics | $5.01 | $0.83 | 19.86% | 231K | $37M | $1.81$5.06 |
| WTI | W&T Offshore | $3.75 | $0.61 | 19.43% | 258.7K | $467M | $1.09$4.04 |
| PLYX | Polaryx Therapeutics | $3.27 | $0.53 | 19.34% | 174K | $130M | $2.20$48.91 |
| NERV | Minerva Neurosciences | $7.12 | $1.11 | 18.47% | 53.6K | $260M | $1.15$12.46 |
| CRCG | Themes ETF Trust - Leverage Shares 2x Long Crcl Daily ETF | $4.06 | $0.59 | 16.86% | 17.5M | - | $0.95$20.92 |
| BEG | Themes ETF Trust - Leverage Shares 2x Long Be Daily ETF | $30.25 | $4.11 | 15.72% | 25.2K | - | $10.89$50.61 |
| EDIT | Editas Medicine | $2.31 | $0.31 | 15.50% | 87.8K | $195M | $0.91$4.54 |
| KC | Kingsoft Cloud | $13.83 | $1.84 | 15.30% | 56.2K | $3.5B | $10.29$19.57 |
| PURR | Hyperliquid Strategies | $4.96 | $0.63 | 14.48% | 2.1M | $537M | $3.01$5.78 |
| DDD | 3D Systems | $2.24 | $0.28 | 14.29% | 50.9K | $252M | $1.32$3.80 |
| VRTL | GraniteShares ETF Trust - GraniteShares 2x Long Vrt Daily ETF | $112.74 | $13.85 | 14.00% | 106.9K | - | $7.57$119.89 |
| AXTI | AXT | $36.89 | $4.52 | 13.97% | 4M | $1.8B | $1.13$47.03 |
| PLBL | Polibeli Group | $9.20 | $1.06 | 13.02% | 14 | $3.0B | $5.60$14.31 |
| MLCIL | Mount Logan Capital | $23.25 | $0.25 | 1.09% | 3.2K | - | $23.00$24.50 |
| RWTN | Redwood Trust | $25.01 | $0.02 | 0.08% | 1.5K | - | $22.48$25.77 |
Related Articles
Featured Article
Down 70% Over the Past Year, Can Hims & Hers Health Stock Bounce Back?
Geoffrey Seiler|Feb 27, 2026
The company is looking toward international markets to boost its growth.
Hims & Hers HUGE Acquisition News!
Travis Hoium|Feb 19, 2026
Hims & Hers is acquiring Eucalyptus and spreading its wings internationally.
Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
Bram Berkowitz|Feb 9, 2026
Hims & Hers could face difficulty in the future in selling copycat GLP-1 drugs.
Hims & Hers Takes On Novo Nordisk: What We Know Right Now
Travis Hoium|Feb 5, 2026
Hims & Hers fell on fear that Novo Nordisk would take action against the company's new oral GLP-1, but there's more to the story.
HUGE News: Hims & Hers Adds Cancer Testing to Labs Offering
Travis Hoium|Feb 4, 2026
Hims & Hers is moving beyond prescriptions to preventative testing.
Stocks to Love in 2026
Motley Fool Staff|Jan 11, 2026
Are you looking for investment opportunities in 2026?
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip?
Parkev Tatevosian, CFA|Nov 26, 2025
The healthcare industry is ripe for disruption.
Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock?
Geoffrey Seiler|Nov 9, 2025
The company continues to have a strong growth outlook ahead.
Hims & Hers Stock Jumps 9% After Huge Announcement
Travis Hoium|Oct 16, 2025
New products are coming to the Hers platform.
